Identification of proteins that bind to LrrB in an SH2 domain-dependent manner. A, structure of LrrB-CTAP and LrrB-CTAPmutR. B, Western blot with an anti-phosphotyrosine antibody of samples from a TAP purification of LrrB-CTAP and LrrB-CTAPmutR after treatment with and without pervanadate. Bands marked a, b, and c are described in the text. C, portion of a colloidal Coomassie staining of a gel bearing a much larger amount of the same samples analyzed in B. The full colloidal Coomassie-stained gel is presented in supplemental Fig. S2. The 130 kDa band (marked as a?) was excised and subjected to tandem mass spectrometry, in parallel with the equivalent gel region taken from the control, non-pervanadate-treated sample. Three proteins were found to be unique to the pervanadate-treated LrrB-CTAP-purified sample. Neither large protein, DDB_G0278895 (CldA, 145 kDa) nor DDB_G0276091 (CldB, 164 kDa), migrate at the sizes expected. This could reflect anomalous migration because of their very large size, or it could indicate the presence of a secondary modification, such as ubiquitination; ubiquitin was the third protein present in band a. D, co-immunoprecipitation (IP) experiments carried out, using the antibodies stated, on extracts from Ax2 co-transformed with LrrB-GFP and CldA-CTAP (right) or with LrrB-GFP and CTAP as a control (left) and analyzed by Western blotting with an anti-GFP antibody. E, co-immunoprecipitation experiments carried out, using the antibodies stated, on extracts from Ax2 co-transformed with LrrB-GFP and CldA-CTAP (right) or with LrrB-GFP and CTAP as a control (left) and analyzed by Western blotting with an anti-TAP antibody. IgG L, IgG light chain carried over from the immunoprecipitation.